It kind of seems that the last 6 months accumulation hasn't had the frenetic selling that many longs got used to over the last couple of years. There is just too much happening in the company. My guess is as good as yours. We may start to hear of the effect Iluvien is having in patients in the EU. We may start to hear the buzz of the tech agreements having positive results to deliver proteins with the "global" pharmas. Either way the word is out and we are beginning to show on the radars of long biased investors, and that's very good indeed.
OK, We can now see the true shedding of weak longs, perhaps some short covering. The volume would certainly seem to indicate solid accumulation going strong. This is all happening on very little news. We have had some good press lately, and rightly so, real news will carry yet higher.
You are right, it is a combination of all the good things PSDV has been accomplishing over the last few months and even years and now investors are taking notice. I like it, we have more than just one deal going, we have a basket of opportunities for investors. As someone said recently the market looks out as much as 4 yrs on valuations,especially in the pharma field.